Published in Hepatology on January 13, 2014
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | NCT01150916
Evaluation of New-Onset Ascites. JAMA (2016) 1.39
Cardiohepatic interactions--from humoral theory to organ transplantation. Arq Bras Cardiol (2014) 0.75
Role of plasma BNP in patients with ascites: advantages and pitfalls. Hepatology (2014) 0.75
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol (2005) 6.22
Vascular disorders of the liver. Hepatology (2009) 5.38
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09
Acute-on chronic liver failure. J Hepatol (2012) 3.74
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50
Bacterial translocation (BT) in cirrhosis. Hepatology (2005) 3.07
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (2005) 2.91
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology (2008) 2.69
Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis (2008) 2.47
Impact of the severity of end-stage liver disease in cardiac structure and function. Ann Hepatol (2013) 2.37
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int (2010) 2.32
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16
Schistosoma mansoni infection in the liver graft: The impact on donor and recipient outcomes after transplantation. Liver Transpl (2011) 2.13
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int (2008) 2.10
Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01
Sildenafil vs. sodium before nitroprusside for the pulmonary hypertension reversibility test before cardiac transplantation. Arq Bras Cardiol (2012) 2.01
Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease. Int J Cardiol (2013) 1.98
[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]. Arq Bras Cardiol (2011) 1.90
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89
Long-term nutritional outcome after gastric bypass. Obes Surg (2009) 1.85
Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76
[Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC]. Arq Bras Cardiol (2011) 1.64
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial. Circ Heart Fail (2009) 1.62
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J Clin Gastroenterol (2009) 1.56
Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant (2008) 1.55
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
[III Brazilian Guidelines on Chronic Heart Failure]. Arq Bras Cardiol (2009) 1.54
Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol (2005) 1.51
Potassium in hemorrhagic shock: a potential marker of tissue hypoxia. J Trauma (2010) 1.51
Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Liver Int (2010) 1.49
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am J Gastroenterol (2004) 1.43
Critical analysis of the use of statistical tests in Brazilian publications related to digestive tract surgery. Rev Assoc Med Bras (2011) 1.42
Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study. Eur J Heart Fail (2012) 1.40
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol (2007) 1.39
Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol (2010) 1.36
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial. Circ Heart Fail (2008) 1.31
Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study. J Med Chem (2003) 1.31
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int (2012) 1.29
Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing. J Virol (2012) 1.29
Management of hepatic hemangiomas: a 14-year experience. J Gastrointest Surg (2005) 1.26
[II Brazilian Guidelines for Cardiac Transplantation]. Arq Bras Cardiol (2010) 1.24
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology (2008) 1.24
[Updating of the Brazilian guideline for chronic heart failure - 2012]. Arq Bras Cardiol (2012) 1.22
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21
Patients' preferences for treatment of hepatitis C. Med Decis Making (2009) 1.20
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat (2004) 1.16
High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol (2012) 1.15
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep (2009) 1.14
Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis (2010) 1.09
Cardiac dysfunction related to cirrhosis. Arq Bras Cardiol (2013) 1.07
Early-onset and late-onset heart failure after liver transplantation. Liver Transpl (2013) 1.07
[I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol (2011) 1.06
Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study. Hepatogastroenterology (2003) 1.06
Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire. Arq Bras Cardiol (2009) 1.05
Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol (2007) 1.05
Postoperative portal vein thrombosis in patients with hepatosplenic mansonic schistosomiasis: relationship with intraoperative portal pressure and flow. A prospective study. Hepatogastroenterology (2005) 1.05
What do patients consider when making decisions about treatment for hepatitis C? Am J Med (2005) 1.03
The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis (2010) 1.02
Exhaled acetone as a new biomaker of heart failure severity. Chest (2012) 1.02
Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol (2008) 1.02
Patients' experiences related to anti-viral treatment for hepatitis C. Patient Educ Couns (2005) 1.01
Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol (2009) 1.01
Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol. Am J Cardiol (2004) 0.99
I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol (2011) 0.99
A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology (2008) 0.97
MicroRNAs: new players in heart failure. Mol Biol Rep (2012) 0.97
Reversible pulmonary trunk banding III: assessment of myocardial adaptive mechanisms-contribution of cell proliferation. J Thorac Cardiovasc Surg (2007) 0.97
Multiple angiomyolipomata of the liver: a case report. Mod Pathol (2002) 0.97
Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: a comparative study in schistomomal portal hypertension. World J Gastroenterol (2007) 0.95
Contrast echocardiography can save nondiagnostic exams in mechanically ventilated patients. Echocardiography (2005) 0.94
Importance of adequately performed Valsalva maneuver to detect patent foramen ovale during transesophageal echocardiography. J Am Soc Echocardiogr (2013) 0.94
Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res (2012) 0.93
Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology (2012) 0.93
Left lateral segmentectomy for pediatric live-donor liver transplantation: special attention to segment IV complications. Transplantation (2008) 0.93
Psychosocial issues in hepatitis C: a qualitative analysis. Psychosomatics (2009) 0.93
High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects. Nutrition (2008) 0.93
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure. Arq Bras Cardiol (2007) 0.93
Effects of home-based exercise training on neurovascular control in patients with heart failure. Eur J Heart Fail (2006) 0.92
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. J Am Coll Cardiol (2003) 0.92
Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System. Am J Clin Oncol (2016) 0.92
Classification of cirrhosis: the clinical use of HVPG measurements. Dis Markers (2011) 0.92
Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol (2013) 0.92
Interrupted aortic arch with cardiac heart failure in young adult. Arq Bras Cardiol (2008) 0.91
Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial. PLoS Negl Trop Dis (2013) 0.91
I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol (2013) 0.90
I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure. Arq Bras Cardiol (2005) 0.90
Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol (2008) 0.90
Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis. Hepatology (2013) 0.90